Get High Returns: Long PsycheMedicscompany with a few decades of history, niche product/ market, remains fairly innovative
debt vs. cash +cash flow is net positive. low share count float
Buyout Target
Drugapproval
$CTRV Runway Is Cleared for Take-Off$CTRV to present at the 2017 Marcum MicroCap Conference being held June 15-16. 2017, at the Grand Hyatt New York in New York City .60s on this stock has always been a massive support level since 2014. Go back far enough and you can see where the stock hits .60 and then moves back to multi-dollars. This CEO doesn't do R/S's he is an old school OG who knows how to move a stock and takes care of his shareholders while at the same time taking care of the company and business. Not to mention 3 drug candidates in clinical trials. Liking what I'm seeing here.
up channelshould continue to rise in channel. PDUFA date is June 28. as date nears, will probably break channel on the upside in anticipation of drug approval.
